HOME | COUNTRIES | CITIES | COMPANIES | SPORTS | CARS
news videos images websites wiki
 

Gilead Sciences NEWS

Global Sterile Injectable Market Share Evaluation: Gilead Sciences , Johnson & Johnson, AstraZeneca plc ...  -  Business Services
The global Sterile Injectable industry research report offers a detailed analysis of the current status of the Sterile Injectable market 2018. This extensive Global Sterile Injectable Market research report contains a brief on market trends that can ...
Should You Follow These Analysts?: Gilead Sciences, Inc. (GILD)  -  Nasdaq Place (press release)
Gilead Sciences, Inc. (GILD) declared gain 0.30% in latest trading session with settlement price of $ 67.83. The stock's changed hands 6.21 million shares in session while it possesses an average volume of 7.25 million shares. The stock of GILD ...
Mondrian Investment Partners LTD Has Boosted Gilead Sciences (GILD) Position; UTILICRAFT AEROSPACE ...  -  MoneyMakingArticles
Mondrian Investment Partners Ltd increased Gilead Sciences (GILD) stake by 1.03% reported in 2017Q4 SEC filing. Mondrian Investment Partners Ltd acquired 7,961 shares as Gilead Sciences (GILD)'s stock rose 1.93%. The Mondrian Investment Partners ...
How Does Gilead Sciences, Inc. (GILD) Stack Up Right Now?  -  StockNewsJournal
Gilead Sciences, Inc. (GILD) is an interesting player in the Healthcare space, with a focus on Biotechnology. The stock has been active on the tape, currently trading at $67.83, up from yesterday's close by 0.30%. Given the stock's recent action, it ...
iAB Financial Bank Has $229000 Holding in Gilead Sciences, Inc. (GILD)  -  BangaloreWeekly
iAB Financial Bank boosted its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD) by 5.5% during the third quarter, Holdings Channel reports. The institutional investor owned 2,900 shares of the biopharmaceutical company's stock after buying an ...
As Gilead Sciences INC (GILD) Stock Rose, Van Cleef Asset Managementinc Has Upped Holding by $4.48 Million  -  NMSU Herald
$4.68 million worth of Gilead Sciences, Inc. (NASDAQ:GILD) shares were sold by WILSON GAYLE E. $8.02M worth of Gilead Sciences, Inc. (NASDAQ:GILD) was sold by Meyers James R on Tuesday, January 16. Washington Robin L also sold $401,566 ...
Van Cleef Asset Managementinc Maintains Stake in Gilead Sciences INC (GILD)  -  Gоldmаn Blоg (blog)
$3.61 million worth of Gilead Sciences, Inc. (NASDAQ:GILD) was sold by MARTIN JOHN C. 100,000 shares were sold by Meyers James R, worth $8.02 million on Tuesday, January 16. $401,566 worth of Gilead Sciences, Inc. (NASDAQ:GILD) shares were ...
Van Cleef Asset Managementinc Holds Position in Gilead Sciences INC (GILD)  -  BZ Weekly
Van Cleef Asset Managementinc increased its stake in Gilead Sciences Inc (GILD) by 94.66% based on its latest 2017Q4 regulatory filing with the SEC. Van Cleef Asset Managementinc bought 63,096 shares as the company's stock rose 1.93% while stock ...
Gilead Sciences INC (GILD) Shareholder Van Cleef Asset Managementinc Has Raised Its Stake by $4.48 Million as ...  -  Frisco Fastball
Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gilead Sciences Inc. and related companies with MarketBeat's FREE daily ratings newsletter.
Gilead Sciences INC (GILD) Position Raised by Van Cleef Asset Managementinc  -  The Malibu Report
$8.02 million worth of Gilead Sciences, Inc. (NASDAQ:GILD) was sold by Meyers James R. On Friday, February 9 WILSON GAYLE E sold $4.68 million worth of Gilead Sciences, Inc. (NASDAQ:GILD) or 60,000 shares. MARTIN JOHN C also sold $3.68 million ...
 

Gilead Sciences Videos

Gilead Sciences, Inc: A Commitment To Innovation
10:50:19
Gilead Sciences, Inc: A Commitment To Innovation
Gilead Sciences
17:59:12
Gilead Sciences
Is Gilead Sciences Stock a buy in July 2017? - Gilead Stock Analysis
06:23:16
Is Gilead Sciences Stock a buy in July 2017? - Gilead Stock Analysis
What's Gilead Sciences Doing With All That Cash?
17:39:09
What's Gilead Sciences Doing With All That Cash?
Wunschanalyse: Gilead Sciences Aktie
07:12:50
Wunschanalyse: Gilead Sciences Aktie
Gilead Sciences
22:23:52
Gilead Sciences
Gilead Sciences Celebrates Transgender Awareness Week
22:14:54
Gilead Sciences Celebrates Transgender Awareness Week
Gilead HIV: The Goal of Undetectable
21:07:58
Gilead HIV: The Goal of Undetectable
Gilead Sciences, Inc. Dividend Analysis - January 19, 2018
04:56:43
Gilead Sciences, Inc. Dividend Analysis - January 19, 2018
Gilead to Buy Kite for $11.9 Billion in Cancer Megadeal
17:27:59
Gilead to Buy Kite for $11.9 Billion in Cancer Megadeal
 

Gilead Sciences Images

PC location maps by campus | Sheffield Hallam University
PC location maps by campus | Sheffield Hallam University
Buy Sovaldi Online | Life Relay Health Care Solutions Inc.
Buy Sovaldi Online | Life Relay Health Care Solutions Inc.
Bioequivalence of a Fixed-Dose Combination of Rilpivirine ...
Bioequivalence of a Fixed-Dose Combination of Rilpivirine ...
Trade of the Day - PowerShares QQQ (QQQ) | InvestorPlace
Trade of the Day - PowerShares QQQ (QQQ) | InvestorPlace
HIV Dart/2016: Antiviral Activity of Tenofovir Alafenamide ...
HIV Dart/2016: Antiviral Activity of Tenofovir Alafenamide ...
Surprising price break for newly-approved hepatitis C drug
Surprising price break for newly-approved hepatitis C drug
WNCAP Awarded Highly Competitive Grant - WNCAP
WNCAP Awarded Highly Competitive Grant - WNCAP
Status of Truvada (TVD) for HIV Pre-Exposure Prophylaxis ...
Status of Truvada (TVD) for HIV Pre-Exposure Prophylaxis ...
FDA OKs new drug to treat all forms of hepatitis C | Daily ...
FDA OKs new drug to treat all forms of hepatitis C | Daily ...
Top Pharmaceutical Companies, 2015 - knoema.com
Top Pharmaceutical Companies, 2015 - knoema.com
 

Gilead Sciences WebSites

Gilead Sciences, Inc. is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines.
Gilead Sciences, Inc., commonly known as Gilead Sciences or Gilead (also styled GILEAD), is an American biopharmaceutical company that researches, develops and commercializes drugs.
Gilead Sciences, Inc. is actively advancing pharmaceuticals to address unmet medical needs for patients living with life-threatening diseases globally.
Get Gilead Sciences Inc (GILD:NASDAQ) real-time stock quotes, news and financial information from CNBC.
Gilead Sciences #47 on the Forbes America's Largest Public Companies List
Please connect to the Gilead network via VPN to access this webpage.
Discover the Gilead Advancing Access® program, committed to helping you afford your medication every step of the way.
Free stocks price quote for GILD. Latest real-time Bats price quote, charts, financials, technicals and opinions.
Gilead Sciences Inc. stock price, stock quotes and financial overviews from MarketWatch.
GILD's dividend yield, history, payout ratio, proprietary DARS™ rating & much more! Dividend.com: The #1 Source For Dividend Investing...
 

Gilead Sciences Wiki

Gilead Sciences, Inc., commonly known as Gilead Sciences or Gilead (also styled GILEAD), is an American biopharmaceutical company that researches, develops and commercializes drugs. The company focuses primarily on antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi.Headquartered and founded in Foster City, California, Gilead is a member of the NASDAQ Biotechnology Index and the S&P 500.

Northwest ga Northwest Georgia News The states next governor, whoever he or she may be, will likely decide the fate of the vacant Northwest Georgia Regional Hospital campus in Romehats the message local leaders got when they questioned state lawmakers at the Rome Floyd Chambers

LabCorp Enterprise Leader Mackay Shields LLC bought a new position in shares of LabCorp (NYSE:LH) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC)he firm bought 17,137 shares of the medical research

Sauer Danfoss Law360 Law360, Wilmington (December 12, 2016, 6:43 PM EST) -- Industrial manufacturer Sauer - Danfoss Inchareholders who challenged Danfoss A/S $700 million take-private bid in 2013 have settled their putative class action alleging Danfoss got a sweetheart

mcintosh laboratory Expert Consulting manufacturer/player; the top players including Alpine Electronics, Boston Acoustics, Pioneer, Dynaudio, Bose, Meridian Audio, Harman International Industries, Clarion Global, Burmester Audiosysteme, Bang & Olufsen, Blaupunkt, McIntosh Laboratory

Omni Air International StreetInsiderm Mrollard served in various executive positions for Omni Air International from 1997 until 2009, including as its president and chief executive officer from January 2007 until September 2008rior to his employment with Omni Air International , Mr

Kennametal Danvers Record Macquarie Infrastructure Corporation (NYSE:MIC) currently has a current ratio of 1he current ratio, which is also known as the working capital ratio, is a liquidity ratio that displays the proportion of current assets of a business relative to

synchronized swimming DiscoverHumboldtm The Humboldt Synchro Club has wrapped up another successful season, complete with many firstsoach Leisl Lefebvre says this was the first year the club decided to competeSwimmers ages 7-12 have met on a weekly basis since the fall to continue

beach volleyball ABS-CBN News Pretty ladies in a row, these young Batanguenas arehey were first to enter the Batangas City Sports Coliseum a solid three hours before the first match kicking off the first of the two-day PVL on Tour May 19-20nd these early birds got the first

volvo p1800 RoadandTrackm You have a problemou want a Volvo P1800 and a C4 Corvette, but you only have enough money to buy one or the otherts more common than youd thinkell, thankfully, we have found the solution to this amazingly prevalent problemelcome to You

Micronesia Economic Times The Philippines, Cambodia, Laos, Thailand, Malaysia, Sri Lanka, Vanuatu, Tonga and Micronesia and Papua New Guinea are among the 16 countries that have fallen for Chinas so-called debt book diplomacy, according to a report by the Harvard University